NCT06947902View on ClinicalTrials.gov

Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 30, 2027

Conditions
Airway Disorder
Interventions
DEVICE

High flow

The High Flow Nasal Cannula (HFNC) device (Vapotherm) will be placed through the nostrils for oxygen (2L/kg per min with max of 45L)

DEVICE

Low Flow

The High Flow Nasal Cannula (HFNC) device (Vapotherm) will be placed through the nostrils for oxygen (0.5L/kg per min with max of 5L)

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT06947902 - Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures | Biotech Hunter | Biotech Hunter